These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22315325)

  • 1. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
    Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
    Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
    Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
    Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1.
    Lou MD; Li J; Cheng Y; Xiao N; Ma G; Li P; Liu B; Liu Q; Qi LW
    Br J Pharmacol; 2019 Aug; 176(16):2962-2976. PubMed ID: 31166615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purβ promotes hepatic glucose production by increasing Adcy6 transcription.
    Jia L; Jiang Y; Li X; Chen Z
    Mol Metab; 2020 Jan; 31():85-97. PubMed ID: 31918924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
    Chen Y; Wang B; Ou X; Wu Y; He Y; Lin X; Lin X
    J Virol; 2022 Dec; 96(23):e0102022. PubMed ID: 36394315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity.
    Chen Z; Canet MJ; Sheng L; Jiang L; Xiong Y; Yin L; Rui L
    Mol Metab; 2015 Dec; 4(12):951-60. PubMed ID: 26909311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
    Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
    Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
    Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Hepatic Gluconeogenesis by Nuclear Receptor Coactivator 6.
    Oh GS; Kim SR; Lee ES; Yoon J; Shin MK; Ryu HK; Kim DS; Kim SW
    Mol Cells; 2022 Apr; 45(4):180-192. PubMed ID: 35258009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
    Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
    Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
    Ying W; Mahata S; Bandyopadhyay GK; Zhou Z; Wollam J; Vu J; Mayoral R; Chi NW; Webster NJG; Corti A; Mahata SK
    Diabetes; 2018 May; 67(5):841-848. PubMed ID: 29432123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action.
    Sheng L; Zhou Y; Chen Z; Ren D; Cho KW; Jiang L; Shen H; Sasaki Y; Rui L
    Nat Med; 2012 Jun; 18(6):943-9. PubMed ID: 22581287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide enhanced the hepatic glucagon response through regulation of CREB activity.
    Wang J; Wang D; Lu S; Hu Y; Ge Y; Qin X; Mo Y; Kan J; Li D; Zhang R; Liu Y; Zhang WS
    Clin Nutr; 2024 Feb; 43(2):366-378. PubMed ID: 38142481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model.
    Lee P; Leong W; Tan T; Lim M; Han W; Radda GK
    Hepatology; 2013 Feb; 57(2):515-24. PubMed ID: 22911492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes.
    Saberi M; Bjelica D; Schenk S; Imamura T; Bandyopadhyay G; Li P; Jadhar V; Vargeese C; Wang W; Bowman K; Zhang Y; Polisky B; Olefsky JM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1137-46. PubMed ID: 19706791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.